| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |